- Home
- WYY vs CLGN Comparison
WYY vs CLGN Comparison
Compare WYY & CLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WYY
- CLGN
- Stock Information
- Founded
- WYY 1991
- CLGN 2004
- Country
- WYY United States
- CLGN Israel
- Employees
- WYY N/A
- CLGN N/A
- Industry
- WYY EDP Services
- CLGN Industrial Specialties
- Sector
- WYY Technology
- CLGN Health Care
- Exchange
- WYY Nasdaq
- CLGN Nasdaq
- Market Cap
- WYY 35.6M
- CLGN 22.1M
- IPO Year
- WYY 1998
- CLGN N/A
- Fundamental
- Price
- WYY $3.01
- CLGN $3.18
- Analyst Decision
- WYY Strong Buy
- CLGN Strong Buy
- Analyst Count
- WYY 1
- CLGN 2
- Target Price
- WYY $7.00
- CLGN $11.50
- AVG Volume (30 Days)
- WYY 210.9K
- CLGN 165.3K
- Earning Date
- WYY 05-15-2025
- CLGN 05-28-2025
- Dividend Yield
- WYY N/A
- CLGN N/A
- EPS Growth
- WYY N/A
- CLGN N/A
- EPS
- WYY N/A
- CLGN N/A
- Revenue
- WYY $142,582,209.00
- CLGN $2,472,000.00
- Revenue This Year
- WYY $10.84
- CLGN $2,177.67
- Revenue Next Year
- WYY $12.37
- CLGN $56.52
- P/E Ratio
- WYY N/A
- CLGN N/A
- Revenue Growth
- WYY 24.03
- CLGN N/A
- 52 Week Low
- WYY $2.19
- CLGN $1.55
- 52 Week High
- WYY $6.25
- CLGN $5.63
- Technical
- Relative Strength Index (RSI)
- WYY 35.88
- CLGN 59.91
- Support Level
- WYY $2.90
- CLGN $1.90
- Resistance Level
- WYY $3.27
- CLGN $4.98
- Average True Range (ATR)
- WYY 0.49
- CLGN 0.40
- MACD
- WYY -0.22
- CLGN 0.25
- Stochastic Oscillator
- WYY 5.06
- CLGN 47.52
About WYY WidePoint Corporation
WidePoint Corp is a provider of Technology Management as a Service (TMaaS) that consists of federally certified communications management, identity management, interactive bill presentment and analytics, and Information Technology as a Service solution. Its solutions include Telecom Lifecycle Management, Digital billing communications solutions, and Mobile and Identity management. Geographically the company generates a majority of its revenue from the United States and rest from Europe.
About CLGN CollPlant Biotechnologies Ltd
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.